Stocks finished mixed on Monday as investors considered inflation risks and the implications of a global tax agreement.
Here are some of the market's biggest gainers for Monday:
1. U.S. Concrete | Increase 29%
U.S. Concrete (USCR) - Get Report leaped after the company agreed to be acquired by Vulcan Materials (VMC) - Get Report, a deal valued at $1.29 billion. Vulcan will pay $74 cash for each U.S. Concrete share. The deal is expected to close in the second half.
2. Moderna | Increase 6.6%
Moderna (MRNA) - Get Report traded at a record after the drugmaker filed for European approval of its coronavirus vaccine for use in teenagers. Moderna, which is seeking similar authority from health officials in Canada, said late-stage data from its TeenCove study "met its primary immunogenicity endpoint, successfully bridging immune responses to the adult vaccination." The stock traded on Monday up as much as 11% at $227.71.
3. Eli Lilly | Increase 10%
Shares of Eli Lilly (LLY) - Get Report advanced after the Food and Drug Administration cleared aducanumab, Biogen's (BIIB) - Get Report highly anticipated Alzheimer's disease drug. Eli Lilly is one of several companies that are also working on Alzheimer's treatments. Cassava Sciences (SAVA) - Get Report was also rising on the news.
4. AMC Entertainment | Increase 15%
Meme stock favorite AMC Entertainment (AMC) - Get Report rose. Meanwhile, the U.S. Securities and Exchange Commission said it was scrutinizing markets for signs of manipulation and other misconduct as the theater chain operator and other meme stocks continue to surge, Bloomberg reported.